Medgenics Inc (NYSE MKT LLC:MDGN)

8.10
Delayed Data
As of 1:59pm ET
 +0.04 / +0.50%
Today’s Change
3.68
Today|||52-Week Range
8.50
+60.08%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$200.2M

Company Description

Medgenics, Inc. is a medical technology and therapeutics company, which develops protein therapeutics medical therapies. It develops Biopump technology which is used for the treatment of a range of chronic diseases and its product pipeline includes Epodure, Infradure and Hemodure The Company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA.

Contact Information

Medgenics, Inc.
Building 700
Wayne Pennsylvania 19087
P:(610) 254-4201
Investor Relations:

Employees

Shareholders

Mutual fund holders7.53%
Individual stakeholders18.32%
Other institutional14.26%

Top Executives

Michael F. ColaPresident, Chief Executive Officer & Director
John Harold LeamanChief Financial Officer
Nir ShapirVice President-Research & Development
Garry Arthur NeilChief Scientific Officer
Phyllis K. BellinSecretary, Treasurer, CAO & VP-Administration

To view my watchlist

Not a member yet?

Sign up now for a free account